biohaven: "rimegepant pivotal phase 3 trial results -- conference call."
.
.
"the big unanswered question is concerns over safety in pregnancy," she says. cgrp levels are lower than normal in pregnant women who have
.
.
.
.
.
scottish widows to launch mass market drawdown
.